Background: Hypertrophic scars are fibroproliferative lesions caused by abnormal wound healing and involve complex vascular and fibrotic processes. Current treatments often yield variable outcomes, supporting interest in multimodal approaches that target different components of scar pathology. Case Presentation: A 30-year-old male presented with a traumatic hypertrophic scar on the dorsum of the right hand following a degloving/avulsion injury involving deep dermal and subcutaneous tissue. After immediate surgical debridement, the patient received two months of biweekly polydeoxyribonucleotide (PDRN) injections and regenerative laser therapy without noticeable improvement. After an 8-month treatment free interval, the patient underwent six biweekly sessions combining vascular laser, fractional ablative laser, radiofrequency microneedling, and topical exosome-based therapy, alternating with vascular laser monotherapy. Outcomes were assessed using the Vancouver Scar Scale (VSS) and Global Aesthetic Improvement Scale (GAIS). Results: Vascularity, pliability, scar height, and overall appearance improved progressively. The VSS score decreased from 10 at baseline to 4 after six sessions, with a transition from a purple, firm, raised scar to a pink, supple, and flat lesion. GAIS improved from 3 after the second session to 1 after the fifth and sixth sessions. Residual hyperpigmentation persisted. No treatment-related adverse events were observed. Conclusion: This case highlights the potential of a minimally invasive, multimodal approach to improve vascularity and remodeling in traumatic hypertrophic scars. Further studies are required to validate these findings.
| Published in | International Journal of Clinical Dermatology (Volume 9, Issue 2) |
| DOI | 10.11648/j.ijcd.20260902.15 |
| Page(s) | 140-144 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2026. Published by Science Publishing Group |
Energy-based Therapy, Exosome Therapy, Hypertrophic Scar, Multimodal Treatment, Radiofrequency Microneedling, Regenerative Medicine, Scar Remodeling, Traumatic Scar
| [1] | Fang X, Wang Y, Chen H, et al. Hypertrophic scarring and keloids: epidemiology, molecular pathogenesis, and therapeutic interventions. MedComm (2020). 2025; 6(10): e70381. |
| [2] | Bharadia SK, Burnett L, Gabriel V. Hypertrophic scar. Phys Med Rehabil Clin N Am. 2023; 34(4): 783–798. |
| [3] | Carswell L, Borger J. Hypertrophic scarring keloids. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025. |
| [4] | Kazemeini S, Nadeem-Tariq A, Hajian P, et al. Hypertrophic and keloid scar management: advances in diagnosis, perioperative care, and anesthetic modulation. Cureus. 2025; 17(7): e88810. |
| [5] | Yepuri V, Patil AD, Fritz K, et al. Light-based devices for the treatment of facial erythema and telangiectasia. Dermatol Ther (Heidelb). 2021; 11(6): 1879–1887. |
| [6] | Zhang L, Liu C, Li L. An overview of the mechanisms of fractional CO2 laser in scar treatment. Lasers Med Sci. 2026; 41(1): 42. |
| [7] | Shauly O, Marxen T, Menon A, et al. Radiofrequency microneedling: technology, devices, and indications in the modern plastic surgery practice. Aesthet Surg J Open Forum. 2023; 5: ojad100. |
| [8] | Arkoubi AY. Role of exosome therapy in reconstructive surgery: a review. Front Med (Lausanne). 2026; 13: 1697228. |
| [9] | Naik V, Chodankar S, Pereira M, Loliyekar A. The impact of polydeoxyribonucleotide on wound healing: a systematic review. Int Surg J. 2025; 12(4): 568–574. |
| [10] | Ma Y, Barnes SP, Chen YY, Moiemen NS, Lord JM, Sardeli AV. Influence of scar age, laser type and laser treatment intervals on adult burn scars: a systematic review and meta-analysis. PLoS One. 2023; 18(9): e0292097. |
| [11] | Kumar N, Shreya S, Chottawornsak N, et al. Exosomes: revolutionising aesthetic and cosmetic therapeutics. Int J Aesthetic Plast Surg. 2025; 1(3): 248–256. |
| [12] | Park JY, Park JH. Randomized clinical study of laser-assisted delivery of exosome boosters for postoperative facial scars and facial rejuvenation. Life (Basel). 2026; 16(2): 217. |
| [13] | Jeong KH, Park KY, Jung DW. A split-scar study: study of surgical scar using exosomes. J Cosmet Dermatol. 2026; 25(3): e70756. |
| [14] | Kang Y, Yang Y, Yao B, et al. Scar inhibition in wound healing: mechanisms, design, and recent advances. Exploration (Beijing). 2026; 6(1): 20240517. |
| [15] | Mekeres GM, Buhaș CL, Csep AN, et al. The importance of psychometric and physical scales for the evaluation of the consequences of scars—a literature review. Clin Pract. 2023; 13(2): 372–383. |
APA Style
Bock, M. (2026). Minimally Invasive Multimodal Treatment of a Traumatic Hypertrophic Scar Using Energy-Based and Regenerative Therapies: A Case Report. International Journal of Clinical Dermatology, 9(2), 140-144. https://doi.org/10.11648/j.ijcd.20260902.15
ACS Style
Bock, M. Minimally Invasive Multimodal Treatment of a Traumatic Hypertrophic Scar Using Energy-Based and Regenerative Therapies: A Case Report. Int. J. Clin. Dermatol. 2026, 9(2), 140-144. doi: 10.11648/j.ijcd.20260902.15
AMA Style
Bock M. Minimally Invasive Multimodal Treatment of a Traumatic Hypertrophic Scar Using Energy-Based and Regenerative Therapies: A Case Report. Int J Clin Dermatol. 2026;9(2):140-144. doi: 10.11648/j.ijcd.20260902.15
@article{10.11648/j.ijcd.20260902.15,
author = {Minsung Bock},
title = {Minimally Invasive Multimodal Treatment of a Traumatic Hypertrophic Scar Using Energy-Based and Regenerative Therapies: A Case Report},
journal = {International Journal of Clinical Dermatology},
volume = {9},
number = {2},
pages = {140-144},
doi = {10.11648/j.ijcd.20260902.15},
url = {https://doi.org/10.11648/j.ijcd.20260902.15},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijcd.20260902.15},
abstract = {Background: Hypertrophic scars are fibroproliferative lesions caused by abnormal wound healing and involve complex vascular and fibrotic processes. Current treatments often yield variable outcomes, supporting interest in multimodal approaches that target different components of scar pathology. Case Presentation: A 30-year-old male presented with a traumatic hypertrophic scar on the dorsum of the right hand following a degloving/avulsion injury involving deep dermal and subcutaneous tissue. After immediate surgical debridement, the patient received two months of biweekly polydeoxyribonucleotide (PDRN) injections and regenerative laser therapy without noticeable improvement. After an 8-month treatment free interval, the patient underwent six biweekly sessions combining vascular laser, fractional ablative laser, radiofrequency microneedling, and topical exosome-based therapy, alternating with vascular laser monotherapy. Outcomes were assessed using the Vancouver Scar Scale (VSS) and Global Aesthetic Improvement Scale (GAIS). Results: Vascularity, pliability, scar height, and overall appearance improved progressively. The VSS score decreased from 10 at baseline to 4 after six sessions, with a transition from a purple, firm, raised scar to a pink, supple, and flat lesion. GAIS improved from 3 after the second session to 1 after the fifth and sixth sessions. Residual hyperpigmentation persisted. No treatment-related adverse events were observed. Conclusion: This case highlights the potential of a minimally invasive, multimodal approach to improve vascularity and remodeling in traumatic hypertrophic scars. Further studies are required to validate these findings.},
year = {2026}
}
TY - JOUR T1 - Minimally Invasive Multimodal Treatment of a Traumatic Hypertrophic Scar Using Energy-Based and Regenerative Therapies: A Case Report AU - Minsung Bock Y1 - 2026/10/28 PY - 2026 N1 - https://doi.org/10.11648/j.ijcd.20260902.15 DO - 10.11648/j.ijcd.20260902.15 T2 - International Journal of Clinical Dermatology JF - International Journal of Clinical Dermatology JO - International Journal of Clinical Dermatology SP - 140 EP - 144 PB - Science Publishing Group SN - 2995-1305 UR - https://doi.org/10.11648/j.ijcd.20260902.15 AB - Background: Hypertrophic scars are fibroproliferative lesions caused by abnormal wound healing and involve complex vascular and fibrotic processes. Current treatments often yield variable outcomes, supporting interest in multimodal approaches that target different components of scar pathology. Case Presentation: A 30-year-old male presented with a traumatic hypertrophic scar on the dorsum of the right hand following a degloving/avulsion injury involving deep dermal and subcutaneous tissue. After immediate surgical debridement, the patient received two months of biweekly polydeoxyribonucleotide (PDRN) injections and regenerative laser therapy without noticeable improvement. After an 8-month treatment free interval, the patient underwent six biweekly sessions combining vascular laser, fractional ablative laser, radiofrequency microneedling, and topical exosome-based therapy, alternating with vascular laser monotherapy. Outcomes were assessed using the Vancouver Scar Scale (VSS) and Global Aesthetic Improvement Scale (GAIS). Results: Vascularity, pliability, scar height, and overall appearance improved progressively. The VSS score decreased from 10 at baseline to 4 after six sessions, with a transition from a purple, firm, raised scar to a pink, supple, and flat lesion. GAIS improved from 3 after the second session to 1 after the fifth and sixth sessions. Residual hyperpigmentation persisted. No treatment-related adverse events were observed. Conclusion: This case highlights the potential of a minimally invasive, multimodal approach to improve vascularity and remodeling in traumatic hypertrophic scars. Further studies are required to validate these findings. VL - 9 IS - 2 ER -